Burrill & Company
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio0 active
3Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Corcept Therapeutics
2Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Corcept Therapeutics | Biotech | Public | Apr 10, 2012 | $26.2M |
| Nuvelo | Biotech | Acquired | — | — |
| Rigel Pharmaceuticals | Biotech | Public | — | — |
Peer ranks
Portfolio size#136
Portfolio exits#69
Raises, 12 months#88
Co-investors#234
Co-investors
- Bessemer Venture PartnersVenture capital1 shared
- Galen PartnersVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.